FOXM1 mediates resistance to docetaxel in gastric cancerviaup-regulating Stathmin
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FOXM1 mediates resistance to docetaxel in gastric cancerviaup-regulating Stathmin
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 18, Issue 5, Pages 811-823
Publisher
Wiley
Online
2014-03-14
DOI
10.1111/jcmm.12216
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer
- (2013) C Miceli et al. CANCER GENE THERAPY
- Overexpression of Forkhead Box M1 Transcription Factor (FOXM1) is a Potential Prognostic Marker and Enhances Chemoresistance for Docetaxel in Gastric Cancer
- (2012) Kaoru Okada et al. ANNALS OF SURGICAL ONCOLOGY
- Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes
- (2012) Claire Corcoran et al. PLoS One
- Young age, increased tumor proliferation and FOXM1 expression predict early metastatic relapse only for endocrine-dependent breast cancers
- (2011) Christina Yau et al. BREAST CANCER RESEARCH AND TREATMENT
- Mitotic Centromere-associated Kinesin (MCAK) Mediates Paclitaxel Resistance
- (2011) Anutosh Ganguly et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial
- (2010) N C Tebbutt et al. BRITISH JOURNAL OF CANCER
- Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells
- (2010) T-Y Jeon et al. BRITISH JOURNAL OF CANCER
- FoxM1 Mediates Resistance to Herceptin and Paclitaxel
- (2010) Janai R. Carr et al. CANCER RESEARCH
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Stathmin, a New Target of PRL-3 Identified by Proteomic Methods, Plays a Key Role in Progression and Metastasis of Colorectal Cancer
- (2010) Ping Zheng et al. JOURNAL OF PROTEOME RESEARCH
- FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
- (2010) J. M.-M. Kwok et al. MOLECULAR CANCER RESEARCH
- Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
- (2009) Y.-K. Kang et al. ANNALS OF ONCOLOGY
- Critical Role and Regulation of Transcription Factor FoxM1 in Human Gastric Cancer Angiogenesis and Progression
- (2009) Q. Li et al. CANCER RESEARCH
- Hedgehog Target Genes: Mechanisms of Carcinogenesis Induced by Aberrant Hedgehog Signaling Activation
- (2009) Y. Katoh et al. CURRENT MOLECULAR MEDICINE
- Chemotherapy for metastatic gastric cancer: past, present, and future
- (2008) Atsushi Ohtsu JOURNAL OF GASTROENTEROLOGY
- Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression
- (2008) J. M-M. Kwok et al. MOLECULAR CANCER THERAPEUTICS
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- (2008) David Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China
- (2008) Xin-Zu Chen et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started